# Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

> **NCT05640024** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 54 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05640024
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-06
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05640024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05640024, "Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05640024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*